Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease worldwide. Recently several parameters, such as serum ferritin, have emerged as possible predictors for the severity of NAFLD and insulin sensitivity. We aimed to investigate the value of serum ferritin level as a useful biomarker for the prediction of disease severity in patients with NAFLD. Methods: This was a prospective cross sectional study in which demographic, clinical and laboratory data of 101 adult patients with NAFLD were analyzed. Results: In our patients population with mean age of 49.2 years and mean BMI of 31.9, it was also observed that ferritin level did not have a significant correlation with the stage of fibrosis (p = 0.835). Conclusion: Hyperferritinemia is common in patients with NAFLD but the extent of serum ferritin elevations do not predict the stage of underlying NAFLD disease.
Mohammed, E., Hamdy, L., Ahmed, Y., & Ali, N. (2020). Clinical usefulness of serum ferritin level in patients with fatty liver. Minia Journal of Medical Research, 31(2), 201-205. doi: 10.21608/mjmr.2022.221015
MLA
Ehab Mohammed; Lamia Hamdy; Yasser Ahmed; Norhan Ali. "Clinical usefulness of serum ferritin level in patients with fatty liver". Minia Journal of Medical Research, 31, 2, 2020, 201-205. doi: 10.21608/mjmr.2022.221015
HARVARD
Mohammed, E., Hamdy, L., Ahmed, Y., Ali, N. (2020). 'Clinical usefulness of serum ferritin level in patients with fatty liver', Minia Journal of Medical Research, 31(2), pp. 201-205. doi: 10.21608/mjmr.2022.221015
VANCOUVER
Mohammed, E., Hamdy, L., Ahmed, Y., Ali, N. Clinical usefulness of serum ferritin level in patients with fatty liver. Minia Journal of Medical Research, 2020; 31(2): 201-205. doi: 10.21608/mjmr.2022.221015